the buildings where it has operated since relocating ... glass towers that today has become an extension of downtown Boston. Before Vertex showed up, that vision was a long way from reality.
The drug represents a new pathway to treating people with pain due to surgeries or traumatic injuries, avoiding the addictive risks of opioids.
Vertex Pharmaceuticals Inc. is known worldwide for its cystic fibrosis medicines. The Boston drugmaker has won ... not a pill. Building up to a ‘blockbuster’ Myles Minter, a biotech analyst ...
The U.S. Food and Drug Administration said it approved Boston-based Vertex Pharmaceuticals' Journavx for short-term pain that often follows surgery or injuries. It’s the first new ...
BOSTON, January 12, 2025--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced multiple program updates ahead of upcoming investor meetings in January, including the ...
It's the first new pharmaceutical approach to treating pain in over 20 years, designed to eliminate risks of addiction and ...